The Effect of Tocilizumab on the outcome of patients with severe COVID-19 with cytokine storm syndrome in a sample of Iraqi patients
Journal of the Pakistan Medical Association · 2024
DOI: 10.47391/jpma-bagh-16-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Pakistan Medical Association, 2024. Verfasst von Abdul Hameed Alqaseer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Mustansiriyah University, Baghdad, Iraq. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Cytokine Release Syndrome, COVID-19, COVID-19 Drug Treatment. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To determine whether tocilizumab improved outcomes of patients hospitalised with severe coronavirusdisease-2019 cytokine storm syndrome.
Method
The case-control study was conducted at Al-Yarmouk Teaching Hospital, Baghdad, and Al Shatra GeneralHospital, Thi Qar, Iraq, from September 2020 to March 2021, and comprised patients with severe acquiredrespiratory syndrome-corona virus-2 pneumonia who were not candidates for mechanical ventilation and receiveda single-dose intravenous infusion of tocilizumab 8mg/kg in group A. The outcomes were compared with patientsin group B who received only standard care. Data was analysed using SPSS 26.
Results
Of the 60 patients, 30(50%) were in group A; 22(73.3%) males and 8(26.7%) females with mean age56.63±10.92 years. There were 30(50%) patients in control group B; 24(80%) males and 6(20%) females with meanage 54.8±6.18 (p>0.05). Group A showed significant changes compared to group B in the levels of interleukin-6,serum ferritin, D-dimer, procalcitonin, lymphocytes count and oxygen saturation (p0.05).
Conclusions
Majority of the acute phase inflammatory markers were reduced significantly by treatment withtocilizumab.Key Words: Tocilizumab, fibrin, Interleukin, Procalcitonin, Cytokine, Infusions, Intravenous, Oxygen Saturation,Respiration, Artificial, Coronavirus, Lymphocytes, Ferritins
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Mustansiriyah University, Baghdad, Iraq.
- Department of Internal Medicine, Al-Yarmook Teaching Hospital, Baghdad, Iraq.
Zitieren
APA
Alqaseer, A. H., Dhayef, A. K., & Ashor, A. W. (2024). The Effect of Tocilizumab on the outcome of patients with severe COVID-19 with cytokine storm syndrome in a sample of Iraqi patients. Journal of the Pakistan Medical Association. https://doi.org/10.47391/jpma-bagh-16-25
Vancouver
Alqaseer AH, Dhayef AK, Ashor AW. The Effect of Tocilizumab on the outcome of patients with severe COVID-19 with cytokine storm syndrome in a sample of Iraqi patients. Journal of the Pakistan Medical Association. 2024. doi:10.47391/jpma-bagh-16-25
BibTeX
@article{Alqaseer2024,
author = {Alqaseer, Abdul Hameed and Dhayef, Alaa Kareem and Ashor, Ammar Waham},
title = {The Effect of Tocilizumab on the outcome of patients with severe COVID-19 with cytokine storm syndrome in a sample of Iraqi patients},
journal = {Journal of the Pakistan Medical Association},
year = {2024},
doi = {10.47391/jpma-bagh-16-25}
}
EUVIMED